Keratin-Positive Giant Cell-Rich Tumor in Early Infancy: Metastatic Presentation and Imatinib Response
This case expands the clinical spectrum of pediatric KPGCT and suggests that imatinib may be an effective treatment option in infants with advanced disease, even canonical HMGA2::NCOR2 fusion absent.
Authors
- Can Berk Leblebici (ORCID: https://orcid.org/0000-0001-8776-6604)
- Nihal Ekin Dağ (ORCID: https://orcid.org/0000-0003-2384-9798)
- Sonay İncesoy Özdemir (ORCID: https://orcid.org/0000-0003-2863-901X)
- Koray Ceyhan (ORCID: https://orcid.org/0000-0002-6835-8709)
- Handan Dinçaslan (ORCID: https://orcid.org/0000-0002-1015-6784)
- Nur Ayça Çelik (ORCID: https://orcid.org/0000-0002-7750-1781)
- Nurdan Taçyildiz
- Suat Fítöz (ORCID: https://orcid.org/0000-0002-0180-0013)
- Nüket Yürür Kutlay
- CEM Canakci
- Seda Kaynak Şahap
- Vafa Maharramova
- Melda Berber Hamamci
- Nubar Mustafayeva
Institutions
- Pediatric Oncology Group (CA)
- Ankara University (TR)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1097/mph.0000000000003177
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00